Tailoring tolerance to prevent chronic rejection

Transplantation

Volumn 72, Issue 8 SUPPL., 2001, Pages

  Madsen, J C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ALLOIMMUNITY; ANTIGEN RECOGNITION; AUTOIMMUNITY; CONFERENCE PAPER; CYTOKINE PRODUCTION; GRAFT REJECTION; HISTOCOMPATIBILITY; HUMAN; IMMUNOLOGICAL TOLERANCE; MAJOR HISTOCOMPATIBILITY COMPLEX; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

ANIMALS; AUTOIMMUNITY; CHRONIC DISEASE; GRAFT REJECTION; HUMANS; IMMUNE TOLERANCE; INTERFERON TYPE II; ISOANTIGENS;

EID: 0035960363     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. Chronic allograft dysfunction: Mechanisms and new approaches to therapy
2. Redefining peripheral tolerance in the BALB/c to CBA mouse cardiac allograft model: Vascular and cytokine analysis after transient CD4 T cell depletion
3. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis
4. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
5. Reply to failure of combined costimulatory blockade in animal transplant model
6. Mixed hematopoietic chimerism induces long-term tolerance to cardiac allografts in miniature swine
7. Mechanisms of chronic rejection
8. Rethinking chronic allograft nephropathy: The concept of accelerated senescence
9. Macrophages in chronic rejection and graft vasculopathy: A diverse and dynamic cell with myriad roles
10. Problem of chronic rejection
11. Reduced transplant arteriosclerosis in murine cardiac allografts placed in interferon-gamma knockout recipients
12. Coronary atherosclerosis in transplanted mouse hearts. III. Effects of recipient treatment with a monoclonal antibody to interferon-gamma
13. Interferon-gamma elicits arteriosclerosis in the absence of leukocytes
14. De nevo autoimmunity to cardiac myosin after heart transplantation and its contribution to the rejection process
15. Indirect recognition of allopeptides promotes the development of cardiac allograft vasculopathy
16. Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts
17. Significant frequencies of T cells with indirect anti-donor specificity in heart graft recipients with chronic rejection
18. Assessment of the contribution that direct allorecognition makes to the progression of chronic cardiac transplant rejection in humans
19. Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction
20. Indirect recognition of donor HLA class I peptides in lung transplant recipients with bronchiolitis obliterans syndrome
21. Indirect recognition of donor HLA-DR peptides in organ allograft rejection
22. Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein
23. Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection
24. Triple-drug immunosuppression significantly reduces chronic rejection in noninfected and RCMV-infected rats
25. Features of acute rejection that increase risk for chronic rejection
26. Sequence homology and immunologic cross-reactivity of human cytomegalovirus with HLA-DR beta chain: A means for graft rejection and immunosuppression
27. Human cytomegalovirus encodes a glycoprotein homologous to MHC class I antigens
28. Cutting edge: Anti-CD154 therapeutic antibodies induce infectious transplantation tolerance
29. Loss of tolerance to a maternal kidney transplant is selective for HLA class II: Evidence from trans-vivo DTH and alloantibody analysis